Document is current
Any future updates will be listed below
-
Authors
Gruber, Lars https://orcid.org/0009-0009-9955-1550
Schmidt, Stefan https://orcid.org/0000-0003-2896-3290
Enzlein, Thomas https://orcid.org/0000-0003-1789-4090
Vo, Huong Giang https://orcid.org/0009-0002-2025-6313
Bausbacher, Tobias https://orcid.org/0000-0003-4384-5612
Cairns, James Lucas https://orcid.org/0000-0003-4986-1015
Ucal, Yasemin
Keller, Florian
Kerndl, Martina
Sammour, Denis Abu https://orcid.org/0000-0003-1711-6854
Sharif, Omar https://orcid.org/0000-0001-7899-2343
Schabbauer, Gernot https://orcid.org/0000-0002-7490-8009
Rudolf, Rüdiger https://orcid.org/0000-0002-0833-1053
Eckhardt, Matthias https://orcid.org/0000-0003-1964-9064
Iakab, Stefania Alexandra https://orcid.org/0000-0002-4156-1942
Bindila, Laura https://orcid.org/0000-0001-5538-2008
Hopf, Carsten https://orcid.org/0000-0003-0802-6451
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (161L0212F)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (12FH8I05IA)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (13FH8I09IA)
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg - Mittelbauprogramm
Christian Doppler Forschungsgesellschaft
- License Information
-
More Information
Article History
Received: 6 December 2023
Accepted: 7 May 2025
First Online: 22 May 2025
Competing interests
: Bruker Daltonics co-funded the BMBF-funded projects “Drugs4Future” and “DrugsData” within the framework M 2 Aind, as mandated by BMBF. All other authors declare no competing interests.
